CLBX — Cellbxhealth Share News
0.000.00%
- £9.40m
- £7.84m
- £1.35m
Brief: CellBxHealth Announces Discontinuation Of FDA License For Parsortix System
Brief: CelLBxHealth Says Co Is Rationalising Operations At Guildford Into One Facility
UK's CelLBxHealth preliminary FY revenue misses its expectations due to deferred contracts
Preliminary Fourth Quarter 2025 Financial Results
Board changes
Holding(s) in Company
PDMR Dealing and ESOT Share Purchase
Brief: Cellbxhealth Says Peter Collins Transitions From Interim CEO To CEO
Result of Retail Offer
Update to Admission of Fundraising Shares
Launch of Retail Offer
Result of Oversubscribed Placing and Subscription
Brief: Cellbxhealth Proposes To Raise £6.8 Million At 1.0 Pence Per Share
Proposed Placing and Subscription
Marketing Agreement
CelLBxHealth Presents Proof-of-Concept Study
Brief: Cellbxhealth Seeks To Raise About 6 Million Pounds
Expert Consensus on CTCs; Update on Funding
CHANGE OF NAME